Meritage Homes
MTH
KB Home
KBH
D.R. Horton
DHI
4
Adobe
ADBE
5
Lennar Corp
LEN
US Stock MarketDetailed Quotes
LFCR Lifecore Biomedical
- 6.760
- +0.400+6.29%
Close Apr 30 16:00 ET
- 6.800
- +0.040+0.59%
Post 16:46 ET
250.29MMarket Cap-4.60P/E (TTM)
6.830High6.102Low450.60KVolume6.260Open6.360Pre Close2.99MTurnover2.24%Turnover Ratio21.13P/E (Static)37.03MShares7.99052wk High112.67P/B135.84MFloat Cap3.67952wk Low--Dividend TTM20.09MShs Float16.750Historical High--Div YieldTTM11.45%Amplitude1.510Historical Low6.643Avg Price1Lot Size
Lifecore Biomedical Key Stats
Quarterly+Annual
YOY
| (Q3)Feb 23, 2025 | (Q2)Nov 24, 2024 | (Q1)Aug 25, 2024 | (FY)May 26, 2024 | (Q4)May 26, 2024 | (Q3)Feb 25, 2024 | (Q2)Nov 26, 2023 | (Q1)Aug 27, 2023 | (FY)May 28, 2023 | (Q4)May 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 184.63%1.2M | -574.38%-6.11M | 92.28%-643K | 98.76%-217K | 464.37%8.24M | 87.91%-1.42M | 154.74%1.29M | -656.49%-8.33M | 22.80%-17.44M | -312.77%-2.26M |
| Net income from continuing operations | -194.48%-14.77M | -146.22%-6.57M | -50.92%-16.23M | 112.07%12.01M | 81.97%-7.08M | 142.82%15.63M | 211.03%14.22M | 1.93%-10.75M | 14.70%-99.56M | 29.34%-39.28M |
| Operating gains losses | 139.22%8.24M | 94.43%-1.15M | -350.00%-900K | -192.57%-39.48M | -90.04%2.4M | -201.74%-21M | -94,104.55%-20.68M | 90.51%-200K | 651.86%42.65M | 9,424.90%24.1M |
| Depreciation and amortization | 3.49%2.08M | 15.74%2.04M | -8.07%1.99M | -32.77%8.86M | 9.33%2.92M | -37.57%2.01M | -39.93%1.77M | -50.21%2.17M | -27.04%13.18M | -25.27%2.67M |
| Deferred tax | ---- | 372.50%109K | -231.58%-100K | -54.34%163K | ---- | ---- | -1,100.00%-40K | 547.06%76K | 105.23%357K | 122.16%300K |
| Other non cash items | 2.82%5.4M | 35.15%4.92M | 55.85%4.72M | 1,360.34%15.61M | 280.68%3.69M | 34,940.00%5.26M | 3,401.92%3.64M | 16,922.22%3.03M | 350.94%1.07M | 749.12%968K |
| Change In working capital | 48.44%-2.44M | -1,200.76%-8.7M | 277.74%7.47M | -119.43%-3.85M | -40.36%4.3M | -739.46%-4.73M | -84.12%790K | -161.16%-4.2M | 738.21%19.79M | 26.22%7.21M |
| -Change in receivables | -186.39%-3.68M | -39.49%-5.02M | 152.26%6.02M | -122.10%-2.39M | -94.36%106K | 63.67%-1.29M | -168.60%-3.6M | -67.04%2.39M | 276.34%10.82M | 35.62%1.88M |
| -Change in inventory | 160.08%4.62M | 895.08%2.43M | -95.88%-1.66M | 105.82%862K | -958.33%-309K | 133.69%1.78M | 102.01%244K | -132.82%-849K | -579.40%-14.81M | -99.63%36K |
| -Change in prepaid assets | ---- | ---- | 89.94%-244K | ---- | ---- | ---- | ---- | -228.28%-2.43M | ---- | ---- |
| -Change in payables and accrued expense | -16.78%-4.39M | -264.19%-4.4M | 195.54%3.66M | -129.05%-4.52M | 274.22%4.28M | -146.11%-3.76M | -110.12%-1.21M | -82.34%-3.83M | 162.42%15.55M | 55.18%-2.46M |
| -Change in other current assets | -148.72%-97K | ---- | ---- | 10.39%2.38M | --396K | ---39K | ---- | ---- | 412.92%2.16M | ---- |
| -Change in other current liabilities | ---- | -343.09%-1.09M | 145.61%1.15M | ---- | ---- | ---- | ---246K | ---2.53M | ---- | ---- |
| -Change in other working capital | ---- | -75.39%283K | -147.85%-1.46M | -102.95%-179K | ---- | ---- | 1,697.22%1.15M | 2,728.45%3.05M | 33,855.56%6.08M | 730.00%4.28M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 184.63%1.2M | -574.38%-6.11M | 92.28%-643K | 98.76%-217K | 464.37%8.24M | 87.91%-1.42M | 154.74%1.29M | -656.49%-8.33M | 22.80%-17.44M | -312.77%-2.26M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 124.25%1.54M | 42.03%-2.47M | 32.88%-3.39M | -272.50%-17.92M | 63.70%-2.24M | -217.23%-6.37M | -10.73%-4.26M | -2,136.28%-5.05M | -106.02%-4.81M | 67.20%-6.17M |
| Net PPE purchase and sale | 124.25%1.54M | 42.03%-2.47M | 32.88%-3.39M | 16.58%-17.92M | 68.79%-2.24M | 10.32%-6.37M | -10.73%-4.26M | -50.37%-5.05M | 25.41%-21.48M | 36.84%-7.17M |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -77.32%16.67M | 102.23%1.01M |
| Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 124.25%1.54M | 42.03%-2.47M | 32.88%-3.39M | -272.50%-17.92M | 63.70%-2.24M | -217.23%-6.37M | -10.73%-4.26M | -2,136.28%-5.05M | -106.02%-4.81M | 67.20%-6.17M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -188.80%-6.78M | 611.23%12.52M | -62.75%1.09M | -81.09%7.51M | -102.50%-614K | 216.36%7.64M | -127.79%-2.45M | -24.88%2.93M | 169.62%39.7M | 28.36%24.57M |
| Net issuance payments of debt | -322.30%-6.23M | -349.10%-10.94M | -25.45%1.68M | -11.96%2.75M | -99.54%125K | 108.83%2.8M | -161.66%-2.44M | -43.24%2.26M | 105.63%3.12M | 34.32%26.95M |
| Net common stock issuance | --17K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --4.82M | ---- |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --38.08M | --0 |
| Proceeds from stock option exercised by employees | -216.67%-133K | -1,610.53%-975K | -99.86%1K | --724K | 102.05%99K | ---42K | ---57K | --724K | --0 | ---4.82M |
| Net other financing activities | ---- | ---- | -1,208.89%-589K | 163.85%4.04M | 64.80%-838K | ---- | ---- | 32.84%-45K | -292.80%-6.32M | -157.96%-2.38M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -188.80%-6.78M | 611.23%12.52M | -62.75%1.09M | -81.09%7.51M | -102.50%-614K | 216.36%7.64M | -127.79%-2.45M | -24.88%2.93M | 169.62%39.7M | 28.36%24.57M |
| Net cash flow | ||||||||||
| Beginning cash position | 193.54%9.46M | -36.13%5.52M | -55.68%8.46M | 1,061.96%19.09M | 4.17%3.07M | -52.84%3.22M | 104.69%8.64M | 1,061.96%19.09M | 26.87%1.64M | 59.12%2.95M |
| Current changes in cash | -2,628.38%-4.04M | 172.59%3.94M | 71.84%-2.94M | -160.92%-10.63M | -66.61%5.39M | 96.19%-148K | -307.86%-5.42M | -505.16%-10.45M | 4,913.79%17.45M | 7,749.76%16.14M |
| End cash Position | 76.28%5.42M | 193.54%9.46M | -36.13%5.52M | -55.68%8.46M | -55.68%8.46M | 4.17%3.07M | -52.84%3.22M | 104.69%8.64M | 1,061.96%19.09M | 1,061.96%19.09M |
| Free cash flow | 45.33%-4.26M | -188.60%-8.58M | 69.85%-4.04M | 53.40%-18.14M | 163.62%6M | 58.65%-7.79M | 52.06%-2.97M | -199.93%-13.38M | 25.91%-38.92M | 21.04%-9.44M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025